International Experts Summit on Oncology & Cancer Care (Oncology Summit-2027)

  What Are Exosome-Based Diagnostics and Therapeutics? Understanding the Future of Precision Oncology Exosomes are tiny extracellular vesicles naturally released by almost all human cells, including cancer cells. Although they measure only 30–150 nanometers in diameter, these microscopic particles play a vital role in cell-to-cell communication by transporting proteins, DNA, RNA, microRNAs, lipids, and other bioactive molecules throughout the body. In oncology, exosomes have emerged as one of the most promising biomarkers for precision medicine because they carry molecular information that accurately reflects the biological characteristics of the original tumor. Unlike traditional tissue biopsies, which require invasive surgical procedures and provide only a single snapshot of a tumor, exosome-based technologies enable continuous and minimally invasive monitoring through simple blood, urine, or saliva samples. As cancer progresses, tumor-derived exosomes continuously circulat...

  Introduction Cancer care is entering a new era where healthcare is no longer limited to hospital visits or periodic diagnostic tests. Advances in digital health technologies, artificial intelligence (AI), wearable devices, smartphones, and connected medical sensors are transforming the way oncologists monitor patients throughout their cancer journey. Among these innovations, digital biomarkers have emerged as one of the most promising tools for enabling continuous, personalized, and data-driven cancer care. Unlike conventional biomarkers obtained through blood tests, imaging, or tissue biopsies, digital biomarkers are objective physiological and behavioral data collected through digital devices. These technologies can continuously measure vital signs, physical activity, sleep quality, heart rate variability, respiratory patterns, medication adherence, and patient-reported symptoms. By capturing real-time health information outside traditional clinical settings, digital bioma...

  Meta Title: Precision Prevention in Oncology: The Future of Personalized Cancer Risk Assessment | Oncology Summit-2027 Meta Description Discover how precision prevention in oncology is transforming personalized cancer risk assessment through genomics, biomarkers, AI-driven analytics, and lifestyle-based prevention strategies. Explore the latest innovations shaping the future of cancer prevention and precision medicine at Oncology Summit-2027. Focus Keyphrase Precision Prevention in Oncology Slug precision-prevention-in-oncology-personalized-cancer-risk-assessment Introduction Cancer prevention is undergoing a remarkable transformation as precision medicine reshapes the way healthcare professionals assess, predict, and reduce cancer risk. Traditional cancer prevention strategies have primarily focused on population-wide recommendations, such as smoking cessation, healthy nutrition, physical activity, and routine cancer screening. While these approaches have significa...